A549 cells infected with RSV Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXA9
|
ENSG00000078399.11 | homeobox A9 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HOXA9 | hg19_v2_chr7_-_27205136_27205164 | -0.62 | 3.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_121477039 | 3.19 |
ENST00000257570.5
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr12_-_121476959 | 2.90 |
ENST00000339275.5
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr10_+_91092241 | 1.84 |
ENST00000371811.4
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3 |
chr11_+_57310114 | 1.81 |
ENST00000527972.1
ENST00000399154.2 |
SMTNL1
|
smoothelin-like 1 |
chr12_-_121476750 | 1.37 |
ENST00000543677.1
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr10_-_79397547 | 1.01 |
ENST00000481070.1
|
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr2_+_143635222 | 0.92 |
ENST00000375773.2
ENST00000409512.1 ENST00000410015.2 |
KYNU
|
kynureninase |
chr2_+_143635067 | 0.91 |
ENST00000264170.4
|
KYNU
|
kynureninase |
chr1_+_104615595 | 0.87 |
ENST00000418362.1
|
RP11-364B6.1
|
RP11-364B6.1 |
chr11_-_104905840 | 0.82 |
ENST00000526568.1
ENST00000393136.4 ENST00000531166.1 ENST00000534497.1 ENST00000527979.1 ENST00000446369.1 ENST00000353247.5 ENST00000528974.1 ENST00000533400.1 ENST00000525825.1 ENST00000436863.3 |
CASP1
|
caspase 1, apoptosis-related cysteine peptidase |
chr5_+_38846101 | 0.77 |
ENST00000274276.3
|
OSMR
|
oncostatin M receptor |
chr16_+_15596123 | 0.77 |
ENST00000452191.2
|
C16orf45
|
chromosome 16 open reading frame 45 |
chr6_+_47666275 | 0.77 |
ENST00000327753.3
ENST00000283303.2 |
GPR115
|
G protein-coupled receptor 115 |
chr17_+_58018269 | 0.75 |
ENST00000591035.1
|
RP11-178C3.1
|
Uncharacterized protein |
chr7_-_105926058 | 0.74 |
ENST00000417537.1
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
chr16_+_56691838 | 0.72 |
ENST00000394501.2
|
MT1F
|
metallothionein 1F |
chr17_-_8021710 | 0.69 |
ENST00000380149.1
ENST00000448843.2 |
ALOXE3
|
arachidonate lipoxygenase 3 |
chr5_-_94417186 | 0.68 |
ENST00000312216.8
ENST00000512425.1 |
MCTP1
|
multiple C2 domains, transmembrane 1 |
chr12_-_54778444 | 0.64 |
ENST00000551771.1
|
ZNF385A
|
zinc finger protein 385A |
chr12_+_15475462 | 0.62 |
ENST00000543886.1
ENST00000348962.2 |
PTPRO
|
protein tyrosine phosphatase, receptor type, O |
chr12_-_54778471 | 0.62 |
ENST00000550120.1
ENST00000394313.2 ENST00000547210.1 |
ZNF385A
|
zinc finger protein 385A |
chr11_-_74800799 | 0.61 |
ENST00000305159.3
|
OR2AT4
|
olfactory receptor, family 2, subfamily AT, member 4 |
chr11_+_5646213 | 0.61 |
ENST00000429814.2
|
TRIM34
|
tripartite motif containing 34 |
chr19_+_8455077 | 0.60 |
ENST00000328024.6
|
RAB11B
|
RAB11B, member RAS oncogene family |
chr7_+_120629653 | 0.58 |
ENST00000450913.2
ENST00000340646.5 |
CPED1
|
cadherin-like and PC-esterase domain containing 1 |
chr2_-_31637560 | 0.58 |
ENST00000379416.3
|
XDH
|
xanthine dehydrogenase |
chr17_+_7758374 | 0.58 |
ENST00000301599.6
ENST00000574668.1 |
TMEM88
|
transmembrane protein 88 |
chr16_+_56691911 | 0.57 |
ENST00000568475.1
|
MT1F
|
metallothionein 1F |
chr9_-_21368075 | 0.56 |
ENST00000449498.1
|
IFNA13
|
interferon, alpha 13 |
chr16_+_56691606 | 0.55 |
ENST00000334350.6
|
MT1F
|
metallothionein 1F |
chr12_+_13044787 | 0.54 |
ENST00000534831.1
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A |
chr10_+_47894572 | 0.54 |
ENST00000355876.5
|
FAM21B
|
family with sequence similarity 21, member B |
chr16_+_19078960 | 0.53 |
ENST00000568985.1
ENST00000566110.1 |
COQ7
|
coenzyme Q7 homolog, ubiquinone (yeast) |
chr22_+_22723969 | 0.53 |
ENST00000390295.2
|
IGLV7-46
|
immunoglobulin lambda variable 7-46 (gene/pseudogene) |
chr6_+_35310312 | 0.53 |
ENST00000448077.2
ENST00000360694.3 ENST00000418635.2 ENST00000444397.1 |
PPARD
|
peroxisome proliferator-activated receptor delta |
chr17_+_61086917 | 0.53 |
ENST00000424789.2
ENST00000389520.4 |
TANC2
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
chr1_-_204135450 | 0.53 |
ENST00000272190.8
ENST00000367195.2 |
REN
|
renin |
chr22_-_31324215 | 0.52 |
ENST00000429468.1
|
MORC2
|
MORC family CW-type zinc finger 2 |
chr6_+_71104588 | 0.52 |
ENST00000418403.1
|
RP11-462G2.1
|
RP11-462G2.1 |
chr6_+_24126350 | 0.51 |
ENST00000378491.4
ENST00000378478.1 ENST00000378477.2 |
NRSN1
|
neurensin 1 |
chr4_-_99578789 | 0.51 |
ENST00000511651.1
ENST00000505184.1 |
TSPAN5
|
tetraspanin 5 |
chr15_+_67418047 | 0.51 |
ENST00000540846.2
|
SMAD3
|
SMAD family member 3 |
chr7_+_69064566 | 0.49 |
ENST00000403018.2
|
AUTS2
|
autism susceptibility candidate 2 |
chr5_-_94417314 | 0.48 |
ENST00000505208.1
|
MCTP1
|
multiple C2 domains, transmembrane 1 |
chr7_-_75241096 | 0.47 |
ENST00000420909.1
|
HIP1
|
huntingtin interacting protein 1 |
chr2_-_224467002 | 0.44 |
ENST00000421386.1
ENST00000433889.1 |
SCG2
|
secretogranin II |
chr15_-_41166414 | 0.41 |
ENST00000220507.4
|
RHOV
|
ras homolog family member V |
chr17_+_73663470 | 0.41 |
ENST00000583536.1
|
SAP30BP
|
SAP30 binding protein |
chr22_-_30642782 | 0.41 |
ENST00000249075.3
|
LIF
|
leukemia inhibitory factor |
chr1_-_144866711 | 0.40 |
ENST00000530130.1
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
chr18_+_34124507 | 0.40 |
ENST00000591635.1
|
FHOD3
|
formin homology 2 domain containing 3 |
chrX_+_36246735 | 0.39 |
ENST00000378653.3
|
CXorf30
|
chromosome X open reading frame 30 |
chr5_-_94417339 | 0.39 |
ENST00000429576.2
ENST00000508509.1 ENST00000510732.1 |
MCTP1
|
multiple C2 domains, transmembrane 1 |
chr20_+_32250079 | 0.39 |
ENST00000375222.3
|
C20orf144
|
chromosome 20 open reading frame 144 |
chr18_+_9102669 | 0.38 |
ENST00000497577.2
|
NDUFV2
|
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa |
chr5_+_102200948 | 0.38 |
ENST00000511477.1
ENST00000506006.1 ENST00000509832.1 |
PAM
|
peptidylglycine alpha-amidating monooxygenase |
chr9_+_21440440 | 0.38 |
ENST00000276927.1
|
IFNA1
|
interferon, alpha 1 |
chr16_+_19078911 | 0.37 |
ENST00000321998.5
|
COQ7
|
coenzyme Q7 homolog, ubiquinone (yeast) |
chr10_-_14050522 | 0.37 |
ENST00000342409.2
|
FRMD4A
|
FERM domain containing 4A |
chr14_-_65769392 | 0.37 |
ENST00000555736.1
|
CTD-2509G16.5
|
CTD-2509G16.5 |
chr7_+_55177416 | 0.37 |
ENST00000450046.1
ENST00000454757.2 |
EGFR
|
epidermal growth factor receptor |
chr13_+_53602894 | 0.36 |
ENST00000219022.2
|
OLFM4
|
olfactomedin 4 |
chr12_+_59989918 | 0.36 |
ENST00000547379.1
ENST00000549465.1 |
SLC16A7
|
solute carrier family 16 (monocarboxylate transporter), member 7 |
chr5_+_158737824 | 0.36 |
ENST00000521472.1
|
AC008697.1
|
AC008697.1 |
chr3_+_41241596 | 0.36 |
ENST00000450969.1
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa |
chr17_-_39890893 | 0.35 |
ENST00000393939.2
ENST00000347901.4 ENST00000341193.5 ENST00000310778.5 |
HAP1
|
huntingtin-associated protein 1 |
chr10_+_15001430 | 0.35 |
ENST00000407572.1
|
MEIG1
|
meiosis/spermiogenesis associated 1 |
chr15_-_52030293 | 0.35 |
ENST00000560491.1
ENST00000267838.3 |
LYSMD2
|
LysM, putative peptidoglycan-binding, domain containing 2 |
chr22_+_50609150 | 0.35 |
ENST00000159647.5
ENST00000395842.2 |
PANX2
|
pannexin 2 |
chr1_-_89591749 | 0.35 |
ENST00000370466.3
|
GBP2
|
guanylate binding protein 2, interferon-inducible |
chr1_-_23340400 | 0.34 |
ENST00000440767.2
|
C1orf234
|
chromosome 1 open reading frame 234 |
chr14_+_23938891 | 0.34 |
ENST00000408901.3
ENST00000397154.3 ENST00000555128.1 |
NGDN
|
neuroguidin, EIF4E binding protein |
chrX_+_41583408 | 0.34 |
ENST00000302548.4
|
GPR82
|
G protein-coupled receptor 82 |
chr6_-_25832254 | 0.34 |
ENST00000476801.1
ENST00000244527.4 ENST00000427328.1 |
SLC17A1
|
solute carrier family 17 (organic anion transporter), member 1 |
chr10_-_128210005 | 0.34 |
ENST00000284694.7
ENST00000454341.1 ENST00000432642.1 ENST00000392694.1 |
C10orf90
|
chromosome 10 open reading frame 90 |
chr2_-_177684007 | 0.34 |
ENST00000451851.1
|
AC092162.1
|
AC092162.1 |
chr7_-_27153454 | 0.33 |
ENST00000522456.1
|
HOXA3
|
homeobox A3 |
chr6_-_135818368 | 0.33 |
ENST00000367798.2
|
AHI1
|
Abelson helper integration site 1 |
chr6_-_137539651 | 0.33 |
ENST00000543628.1
|
IFNGR1
|
interferon gamma receptor 1 |
chr17_+_60447579 | 0.32 |
ENST00000450662.2
|
EFCAB3
|
EF-hand calcium binding domain 3 |
chr4_-_72649763 | 0.32 |
ENST00000513476.1
|
GC
|
group-specific component (vitamin D binding protein) |
chr12_+_15475331 | 0.32 |
ENST00000281171.4
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O |
chr2_+_201170596 | 0.32 |
ENST00000439084.1
ENST00000409718.1 |
SPATS2L
|
spermatogenesis associated, serine-rich 2-like |
chr17_-_48450534 | 0.30 |
ENST00000503633.1
ENST00000442592.3 ENST00000225969.4 |
MRPL27
|
mitochondrial ribosomal protein L27 |
chr9_-_134955246 | 0.30 |
ENST00000357028.2
ENST00000474263.1 ENST00000292035.5 |
MED27
|
mediator complex subunit 27 |
chr2_-_154335300 | 0.30 |
ENST00000325926.3
|
RPRM
|
reprimo, TP53 dependent G2 arrest mediator candidate |
chr16_-_18462221 | 0.30 |
ENST00000528301.1
|
RP11-1212A22.4
|
LOC339047 protein; Nuclear pore complex-interacting protein family member A3; Nuclear pore complex-interacting protein family member A5; Protein PKD1P1 |
chr1_-_23886285 | 0.30 |
ENST00000374561.5
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
chr17_-_66951474 | 0.29 |
ENST00000269080.2
|
ABCA8
|
ATP-binding cassette, sub-family A (ABC1), member 8 |
chr5_-_146833485 | 0.29 |
ENST00000398514.3
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chr9_+_78505581 | 0.28 |
ENST00000376767.3
ENST00000376752.4 |
PCSK5
|
proprotein convertase subtilisin/kexin type 5 |
chr6_+_75994755 | 0.28 |
ENST00000607799.1
|
RP1-234P15.4
|
RP1-234P15.4 |
chr4_+_187812086 | 0.28 |
ENST00000507644.2
|
RP11-11N5.1
|
RP11-11N5.1 |
chr1_-_152552980 | 0.28 |
ENST00000368787.3
|
LCE3D
|
late cornified envelope 3D |
chr7_+_135777671 | 0.28 |
ENST00000445293.2
ENST00000435996.1 |
AC009784.3
|
AC009784.3 |
chr6_+_125304502 | 0.28 |
ENST00000519799.1
ENST00000368414.2 ENST00000359704.2 |
RNF217
|
ring finger protein 217 |
chr8_+_145215928 | 0.27 |
ENST00000528919.1
|
MROH1
|
maestro heat-like repeat family member 1 |
chr8_-_67874805 | 0.27 |
ENST00000563496.1
|
TCF24
|
transcription factor 24 |
chr4_-_77328458 | 0.27 |
ENST00000388914.3
ENST00000434846.2 |
CCDC158
|
coiled-coil domain containing 158 |
chr10_+_24755416 | 0.27 |
ENST00000396446.1
ENST00000396445.1 ENST00000376451.2 |
KIAA1217
|
KIAA1217 |
chr7_+_54609995 | 0.27 |
ENST00000302287.3
ENST00000407838.3 |
VSTM2A
|
V-set and transmembrane domain containing 2A |
chr21_+_44313375 | 0.27 |
ENST00000354250.2
ENST00000340344.4 |
NDUFV3
|
NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa |
chr22_-_31364187 | 0.26 |
ENST00000215862.4
ENST00000397641.3 |
MORC2
|
MORC family CW-type zinc finger 2 |
chr2_-_99870744 | 0.26 |
ENST00000409238.1
ENST00000423800.1 |
LYG2
|
lysozyme G-like 2 |
chr12_-_50790267 | 0.26 |
ENST00000327337.5
ENST00000543111.1 |
FAM186A
|
family with sequence similarity 186, member A |
chr5_+_140602904 | 0.26 |
ENST00000515856.2
ENST00000239449.4 |
PCDHB14
|
protocadherin beta 14 |
chr2_-_225811747 | 0.26 |
ENST00000409592.3
|
DOCK10
|
dedicator of cytokinesis 10 |
chr11_+_107650219 | 0.26 |
ENST00000398067.1
|
AP001024.1
|
Uncharacterized protein |
chr5_+_175490540 | 0.26 |
ENST00000515817.1
|
FAM153B
|
family with sequence similarity 153, member B |
chr6_-_51952367 | 0.25 |
ENST00000340994.4
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive) |
chr1_-_43919573 | 0.25 |
ENST00000372432.1
ENST00000372425.4 ENST00000583037.1 |
HYI
|
hydroxypyruvate isomerase (putative) |
chr6_-_133035185 | 0.25 |
ENST00000367928.4
|
VNN1
|
vanin 1 |
chr11_+_57435441 | 0.25 |
ENST00000528177.1
|
ZDHHC5
|
zinc finger, DHHC-type containing 5 |
chr1_+_101702417 | 0.25 |
ENST00000305352.6
|
S1PR1
|
sphingosine-1-phosphate receptor 1 |
chr2_-_106054952 | 0.25 |
ENST00000336660.5
ENST00000393352.3 ENST00000607522.1 |
FHL2
|
four and a half LIM domains 2 |
chr17_+_73663402 | 0.25 |
ENST00000355423.3
|
SAP30BP
|
SAP30 binding protein |
chr2_+_32502952 | 0.24 |
ENST00000238831.4
|
YIPF4
|
Yip1 domain family, member 4 |
chr19_-_47975417 | 0.24 |
ENST00000236877.6
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chr5_-_168006324 | 0.24 |
ENST00000522176.1
|
PANK3
|
pantothenate kinase 3 |
chr5_+_38845960 | 0.24 |
ENST00000502536.1
|
OSMR
|
oncostatin M receptor |
chr13_+_108921977 | 0.24 |
ENST00000430559.1
ENST00000375887.4 |
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b |
chr14_+_45464658 | 0.24 |
ENST00000555874.1
|
FAM179B
|
family with sequence similarity 179, member B |
chr10_+_24738355 | 0.24 |
ENST00000307544.6
|
KIAA1217
|
KIAA1217 |
chr4_-_159644507 | 0.24 |
ENST00000307720.3
|
PPID
|
peptidylprolyl isomerase D |
chr14_+_78174414 | 0.24 |
ENST00000557342.1
ENST00000238688.5 ENST00000557623.1 ENST00000557431.1 ENST00000556831.1 ENST00000556375.1 ENST00000553981.1 |
SLIRP
|
SRA stem-loop interacting RNA binding protein |
chr19_+_9296279 | 0.24 |
ENST00000344248.2
|
OR7D2
|
olfactory receptor, family 7, subfamily D, member 2 |
chr2_+_182850551 | 0.24 |
ENST00000452904.1
ENST00000409137.3 ENST00000280295.3 |
PPP1R1C
|
protein phosphatase 1, regulatory (inhibitor) subunit 1C |
chr1_-_33502441 | 0.24 |
ENST00000548033.1
ENST00000487289.1 ENST00000373449.2 ENST00000480134.1 ENST00000467905.1 |
AK2
|
adenylate kinase 2 |
chr7_+_93535866 | 0.23 |
ENST00000429473.1
ENST00000430875.1 ENST00000428834.1 |
GNGT1
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 |
chrX_-_110655306 | 0.23 |
ENST00000371993.2
|
DCX
|
doublecortin |
chr7_-_3214287 | 0.23 |
ENST00000404626.3
|
AC091801.1
|
LOC392621; Uncharacterized protein |
chr22_-_18111499 | 0.23 |
ENST00000413576.1
ENST00000399796.2 ENST00000399798.2 ENST00000253413.5 |
ATP6V1E1
|
ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 |
chr17_+_41150290 | 0.22 |
ENST00000589037.1
ENST00000253788.5 |
RPL27
|
ribosomal protein L27 |
chr11_-_35440796 | 0.22 |
ENST00000278379.3
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr18_+_9102592 | 0.22 |
ENST00000318388.6
|
NDUFV2
|
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa |
chr22_-_38240316 | 0.22 |
ENST00000411961.2
ENST00000434930.1 |
ANKRD54
|
ankyrin repeat domain 54 |
chr2_-_122262593 | 0.22 |
ENST00000418989.1
|
CLASP1
|
cytoplasmic linker associated protein 1 |
chr10_-_51958906 | 0.22 |
ENST00000489640.1
|
ASAH2
|
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 |
chr17_+_44803922 | 0.22 |
ENST00000465370.1
|
NSF
|
N-ethylmaleimide-sensitive factor |
chr16_-_21868739 | 0.22 |
ENST00000415645.2
|
NPIPB4
|
nuclear pore complex interacting protein family, member B4 |
chr6_+_99282570 | 0.22 |
ENST00000328345.5
|
POU3F2
|
POU class 3 homeobox 2 |
chr7_-_83824169 | 0.22 |
ENST00000265362.4
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
chr12_-_52779433 | 0.22 |
ENST00000257951.3
|
KRT84
|
keratin 84 |
chr14_-_25479811 | 0.22 |
ENST00000550887.1
|
STXBP6
|
syntaxin binding protein 6 (amisyn) |
chrX_+_65384182 | 0.22 |
ENST00000441993.2
ENST00000419594.1 |
HEPH
|
hephaestin |
chr8_+_24151620 | 0.21 |
ENST00000437154.2
|
ADAM28
|
ADAM metallopeptidase domain 28 |
chr6_+_126240442 | 0.21 |
ENST00000448104.1
ENST00000438495.1 ENST00000444128.1 |
NCOA7
|
nuclear receptor coactivator 7 |
chr4_-_71532601 | 0.21 |
ENST00000510614.1
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr18_+_72265084 | 0.21 |
ENST00000582337.1
|
ZNF407
|
zinc finger protein 407 |
chr5_-_33297946 | 0.21 |
ENST00000510327.1
|
CTD-2066L21.3
|
CTD-2066L21.3 |
chr7_+_73106926 | 0.21 |
ENST00000453316.1
|
WBSCR22
|
Williams Beuren syndrome chromosome region 22 |
chr19_-_45926739 | 0.21 |
ENST00000589381.1
ENST00000591636.1 ENST00000013807.5 ENST00000592023.1 |
ERCC1
|
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
chr12_+_14956506 | 0.21 |
ENST00000330828.2
|
C12orf60
|
chromosome 12 open reading frame 60 |
chr12_-_3982548 | 0.21 |
ENST00000397096.2
ENST00000447133.3 ENST00000450737.2 |
PARP11
|
poly (ADP-ribose) polymerase family, member 11 |
chr11_+_47293795 | 0.20 |
ENST00000422579.1
|
MADD
|
MAP-kinase activating death domain |
chr14_+_92789498 | 0.20 |
ENST00000531433.1
|
SLC24A4
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 4 |
chr4_-_186732048 | 0.20 |
ENST00000448662.2
ENST00000439049.1 ENST00000420158.1 ENST00000431808.1 ENST00000319471.9 |
SORBS2
|
sorbin and SH3 domain containing 2 |
chr10_+_124320156 | 0.20 |
ENST00000338354.3
ENST00000344338.3 ENST00000330163.4 ENST00000368909.3 ENST00000368955.3 ENST00000368956.2 |
DMBT1
|
deleted in malignant brain tumors 1 |
chr4_-_74964904 | 0.20 |
ENST00000508487.2
|
CXCL2
|
chemokine (C-X-C motif) ligand 2 |
chr5_-_146833222 | 0.20 |
ENST00000534907.1
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chr5_-_177210399 | 0.20 |
ENST00000510276.1
|
FAM153A
|
family with sequence similarity 153, member A |
chr13_+_98794810 | 0.20 |
ENST00000595437.1
|
FARP1
|
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
chr3_-_151047327 | 0.20 |
ENST00000325602.5
|
P2RY13
|
purinergic receptor P2Y, G-protein coupled, 13 |
chr3_-_143567262 | 0.20 |
ENST00000474151.1
ENST00000316549.6 |
SLC9A9
|
solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9 |
chr17_+_41150479 | 0.19 |
ENST00000589913.1
|
RPL27
|
ribosomal protein L27 |
chr19_-_19739321 | 0.19 |
ENST00000588461.1
|
LPAR2
|
lysophosphatidic acid receptor 2 |
chrX_-_92928557 | 0.19 |
ENST00000373079.3
ENST00000475430.2 |
NAP1L3
|
nucleosome assembly protein 1-like 3 |
chr15_+_33022885 | 0.19 |
ENST00000322805.4
|
GREM1
|
gremlin 1, DAN family BMP antagonist |
chr19_+_37341752 | 0.19 |
ENST00000586933.1
ENST00000532141.1 ENST00000420450.1 ENST00000526123.1 |
ZNF345
|
zinc finger protein 345 |
chr19_-_50529193 | 0.19 |
ENST00000596445.1
ENST00000599538.1 |
VRK3
|
vaccinia related kinase 3 |
chr8_-_116673894 | 0.19 |
ENST00000395713.2
|
TRPS1
|
trichorhinophalangeal syndrome I |
chr2_+_219646462 | 0.19 |
ENST00000258415.4
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1 |
chr7_+_44084233 | 0.18 |
ENST00000448521.1
|
DBNL
|
drebrin-like |
chr1_-_24513737 | 0.18 |
ENST00000374421.3
ENST00000374418.3 ENST00000327535.1 ENST00000327575.2 |
IFNLR1
|
interferon, lambda receptor 1 |
chr3_+_119298280 | 0.18 |
ENST00000481816.1
|
ADPRH
|
ADP-ribosylarginine hydrolase |
chr18_+_63417864 | 0.18 |
ENST00000536984.2
|
CDH7
|
cadherin 7, type 2 |
chr11_-_58035732 | 0.18 |
ENST00000395079.2
|
OR10W1
|
olfactory receptor, family 10, subfamily W, member 1 |
chr13_-_30880979 | 0.18 |
ENST00000414289.1
|
KATNAL1
|
katanin p60 subunit A-like 1 |
chr6_-_46138676 | 0.18 |
ENST00000371383.2
ENST00000230565.3 |
ENPP5
|
ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) |
chr11_+_85955787 | 0.17 |
ENST00000528180.1
|
EED
|
embryonic ectoderm development |
chr4_+_76439095 | 0.17 |
ENST00000506261.1
|
THAP6
|
THAP domain containing 6 |
chr1_-_22109484 | 0.17 |
ENST00000529637.1
|
USP48
|
ubiquitin specific peptidase 48 |
chr2_-_130031335 | 0.17 |
ENST00000375987.3
|
AC079586.1
|
AC079586.1 |
chr11_-_108464465 | 0.17 |
ENST00000525344.1
|
EXPH5
|
exophilin 5 |
chr4_-_48018580 | 0.17 |
ENST00000514170.1
|
CNGA1
|
cyclic nucleotide gated channel alpha 1 |
chr8_+_69242957 | 0.17 |
ENST00000518698.1
ENST00000539993.1 |
C8orf34
|
chromosome 8 open reading frame 34 |
chr10_+_69869237 | 0.17 |
ENST00000373675.3
|
MYPN
|
myopalladin |
chr7_+_119913688 | 0.17 |
ENST00000331113.4
|
KCND2
|
potassium voltage-gated channel, Shal-related subfamily, member 2 |
chr12_+_54402790 | 0.17 |
ENST00000040584.4
|
HOXC8
|
homeobox C8 |
chr9_+_470288 | 0.17 |
ENST00000382303.1
|
KANK1
|
KN motif and ankyrin repeat domains 1 |
chr1_-_31666767 | 0.17 |
ENST00000530145.1
|
NKAIN1
|
Na+/K+ transporting ATPase interacting 1 |
chr19_-_6424783 | 0.17 |
ENST00000398148.3
|
KHSRP
|
KH-type splicing regulatory protein |
chr11_+_118938485 | 0.17 |
ENST00000300793.6
|
VPS11
|
vacuolar protein sorting 11 homolog (S. cerevisiae) |
chr4_+_26344754 | 0.17 |
ENST00000515573.1
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region |
chr8_+_31497271 | 0.17 |
ENST00000520407.1
|
NRG1
|
neuregulin 1 |
chr7_+_65338312 | 0.16 |
ENST00000434382.2
|
VKORC1L1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
chr5_+_140213815 | 0.16 |
ENST00000525929.1
ENST00000378125.3 |
PCDHA7
|
protocadherin alpha 7 |
chr7_+_153584166 | 0.16 |
ENST00000404039.1
|
DPP6
|
dipeptidyl-peptidase 6 |
chr21_+_37507210 | 0.16 |
ENST00000290354.5
|
CBR3
|
carbonyl reductase 3 |
chr2_+_108994633 | 0.16 |
ENST00000409309.3
|
SULT1C4
|
sulfotransferase family, cytosolic, 1C, member 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.8 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.3 | 0.9 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.2 | 0.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 1.3 | GO:1902164 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.2 | 0.5 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.1 | 0.6 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.1 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 1.8 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 1.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.3 | GO:0039023 | pronephric nephron morphogenesis(GO:0039007) pronephric nephron tubule morphogenesis(GO:0039008) pronephric duct development(GO:0039022) pronephric duct morphogenesis(GO:0039023) Kupffer's vesicle development(GO:0070121) |
0.1 | 0.4 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.1 | 0.5 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.1 | 0.7 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.8 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.1 | 0.3 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.1 | 0.4 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.1 | 0.4 | GO:1904499 | glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
0.1 | 0.1 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.1 | 1.0 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.1 | 0.2 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.1 | 0.2 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 0.2 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
0.1 | 0.5 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.1 | 0.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 7.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.3 | GO:0070350 | white fat cell proliferation(GO:0070343) positive regulation of fat cell proliferation(GO:0070346) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 0.4 | GO:0018032 | protein amidation(GO:0018032) |
0.1 | 0.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 1.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.1 | 0.2 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.1 | 0.2 | GO:0021503 | neural fold bending(GO:0021503) |
0.0 | 0.2 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.0 | 0.2 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.0 | 0.5 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 0.4 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.1 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.0 | 0.3 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.3 | GO:0060017 | specification of organ position(GO:0010159) parathyroid gland development(GO:0060017) |
0.0 | 0.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.7 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.0 | 0.1 | GO:0061565 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
0.0 | 0.2 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.0 | 0.4 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.0 | 0.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.9 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.1 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
0.0 | 1.5 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.2 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.1 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.0 | 0.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.2 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.0 | 0.1 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.0 | 0.1 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.0 | 0.1 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.0 | 0.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.2 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.0 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.2 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.0 | 0.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.0 | 1.1 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.0 | 0.1 | GO:0030047 | actin modification(GO:0030047) |
0.0 | 0.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.1 | GO:0048511 | rhythmic process(GO:0048511) |
0.0 | 0.1 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.0 | 0.1 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.0 | 0.2 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.0 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.2 | GO:1901297 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.0 | 0.1 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.0 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.7 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.3 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.0 | 0.2 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.0 | 0.3 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.2 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.0 | 0.1 | GO:1904353 | regulation of telomere capping(GO:1904353) positive regulation of telomere capping(GO:1904355) |
0.0 | 0.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.0 | 0.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.5 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.0 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
0.0 | 0.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.0 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.1 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.1 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.0 | 0.5 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.1 | GO:0051012 | microtubule sliding(GO:0051012) |
0.0 | 0.0 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.4 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.1 | 0.9 | GO:0097169 | NLRP1 inflammasome complex(GO:0072558) AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.6 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.1 | 0.2 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.1 | 0.2 | GO:0031592 | centrosomal corona(GO:0031592) |
0.0 | 0.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.0 | 2.2 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.1 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.0 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.2 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.5 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 1.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 7.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 1.8 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 0.7 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.2 | 1.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.7 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.1 | 0.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.3 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 1.0 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 0.3 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.1 | 0.4 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.1 | 0.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 0.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.4 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.1 | 0.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.3 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.5 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.6 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.1 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.1 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.0 | 0.2 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.0 | 0.3 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.0 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0031626 | beta-endorphin binding(GO:0031626) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.2 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.0 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.9 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.0 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.5 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.5 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.0 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.2 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 1.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.9 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.2 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.0 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
0.0 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) virion binding(GO:0046790) |
0.0 | 0.3 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 10.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.4 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 0.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |